baber/WOPTO huggingface dataset:
Patent EP-1108374-A1 (EP)
Inventor: MATSUSHITA MICHIYO
IPC: A41D13/12
Filed: 1999-12-09
Abstract: An upper garment 1 comprises right- and left-hand sleeve
sheets 4, 5 respectively having inner and outer side edges 4c,
4d; 5c, 5d and arm holes 4e, 5e in the vicinity of their upper
ends and right- and left-hand body sheets 2, 3 respectively
having inner and outer side edges 2c, 2d; 3c, 3d and arm holes
2e, 3e in the vicinity of their upper ends. Each of the right-
and left-hand sleeve sheets 4, 5 is folded onto itself along
its center lines Y2 extending between its upper and lower ends
and bonded along its inner and outer side edges 4c, 4d; 5c, 5d.
The right- and left-hand body sheets 2, 3 are bonded together
along their inner side edges 2d, 3d. The right- and left-hand
sleeve sheets 4, 5 are bonded to the right- and left-hand body
sheets 2, 3, respectively, along peripheral edges of their arm
holes 4e, 2e; 5e, 3e. The right- and left-hand sleeve sheets
4, 5 have their upper edges are respectively sealed together.
Patent EP-1145703-A1 (EP)
Inventor: OKUTOME TOSHIYUKI
IPC: A61M1/36
Filed: 1999-12-24
Abstract: By having a chamber for containing a medicine
in at least a portion of the chamber, an inlet passage
extending between the chamber and an outside of the
container to allow the medicine to be supplied into the
chamber through the inlet passage, a closing part
forming a part of the chamber, a body forming the inlet
passage and another part of the chamber, and a
breakable part between the body and the closing part,
and breaking at least a portion of the breakable part
to separate the closing part from a container, the
medicine is supplied or injected to be contained in the
container for medicine from which the medicine is
discharged to the outside of the container through the
broken breakable portion while the medicine is
prevented from passing the inlet path.
Patent EP-1133480-A1 (EP)
Inventor: MYERS MICHAEL R
IPC: A61M25/10
Filed: 1999-11-23
Abstract: La présente invention concerne des composés de quinoléine/quinoxaline représentés par la formule (I) qui inhibent le facteur de croissance d'origine plaquettaire ou l'activité de la tyrosine kinase p56lck. Par ailleurs, cette invention concerne des compositions pharmaceutiques contenant les composés précités, ainsi que leur utilisation pour traiter un patient souffrant/sujet à des troubles/états impliquant la différenciation cellulaire, la prolifération cellulaire, la production de matrices extracellulaires ou la libération de médiateurs et/ou l'activation ou la prolifération des lymphocytes T.
Patent EP-1139792-A1 (EP)
Inventor: KATTENBERG HANS ROBERT
IPC: A23L27/10
Filed: 1999-12-23
Abstract: L'invention concerne un procédé permettant de récupérer du concentré d'arôme d'un produit alimentaire comprenant de la théobromine ou de la caféine, tel que le café ou le thé, et en particulier le cacao. Ledit procédé consiste à introduire le produit alimentaire dans un agent d'extraction aqueux et à l'incuber à une température et pendant une durée appropriées, l'extraction sensible des arômes se produisant pour former un extrait alimentaire aqueux; à pervaporer l'extrait alimentaire au moyen d'une membrane de pervaporation hydrophobe pour former un perméat d'arôme; à récupérer ledit perméat pour obtenir le concentré d'arôme. Des concentrés alimentaires obtenus par ledit procédé sont également traités.
Patent EP-1139752-A1 (EP)
Inventor: VOURNAKIS JOHN N
IPC: A61L31/04
Filed: 1999-12-21
Abstract: The present invention relates to methods and compositions comprising at least one endothelin antagonist, preferably in combination with a poly- beta -1->4-N-acetylglucosamine (p-GlcNAc) polysaccharide matrix, for use in the treatment of cancer and other proliferative diseases. The endothelin antagonist can be a peptide or non-peptide compound, and the p-GlcNAc matrix of the invention is comprised of a polymer of high molecular weight whose constituent monosaccharide sugars are attached in a  beta -1->4 conformation, and which is free of proteins, and substantially free of single amino acids, and other organic and inorganic contaminants. The compositions and methods of the invention are useful for inhibiting the growth of tumors and other neoplastic cells and/or for inhibiting the metastasis of neoplastic cells in vivo.
Patent EP-1124458-A1 (EP)
Inventor: HAIMERL FRANZ XAVER
IPC: A43D21/00
Filed: 1999-10-28
Abstract: The invention relates to footwear comprising an insole (11; 57) having an insole bottom (23), a shank (15) constructed with an upper material (17), and an end area situated on the side of the sole. The footwear also comprises a water-tight functional layer (21) which at least partially lines the upper material (17) of the shank (15) on the inner side thereof and which has an end area situated on the side of the sole. The shank (15) has a lasting fold (35) which is glued to the insole bottom (23) by means of a lasting adhesive (25) and has a lasting fold bottom (43) pointing away from the insole bottom (23). In addition, an outsole (51, 59) is provided which is glued to the lasting fold bottom (43) by means of an outsole adhesive (45). A water-tight reactive hot-melt adhesive is applied as a lasting adhesive (25).
Patent EP-1129064-A1 (EP)
Inventor: CHU YONGLIANG
IPC: C07C211/21
Filed: 1999-11-12
Abstract: Disclosed are compounds capable of facilitating transport of biologically active agents or substances into cells having general structure (A):
Patent EP-1075597-A1 (EP)
Inventor: REITER FERDINAND
IPC: F02M61/14
Filed: 1999-09-30
Abstract: L'invention concerne un dispositif de montage/démontage (1) servant à monter une soupape d'injection de carburant (22) dans un orifice de logement (21) d'une culasse (20) d'un moteur à combustion interne et à démonter cette même soupape d'injection. Ce dispositif (1) présente une gaine (2) constituée d'une partie tubulaire (4) et d'une partie de contact (3) qui vient en contact avec la soupape d'injection de carburant (22) au moyen d'une surface d'appui (7) faisant saillie vers l'intérieur dans le sens radial. Cette partie de contact (3), qui peut être formée par au moins deux parties de contact (3a, 3b) élastiques, séparées l'une de l'autre par des évidements (11, 12), peut être déplacée entre une position de contact, dans laquelle une liaison de force est établie avec la soupape d'injection de carburant (22), et une position de libération, dans laquelle le dispositif de montage/démontage peut être retiré de la soupape d'injection de carburant (22).
Patent ES-149966-A1 (ES)
Title: PERFECCIONAMIENTOS EN LA FABRICACIoN DE ALPARGATAS
Abstract: Perfeccionamiento en la fabricación de alpargatas y calzado similares que consisten esencialmente en emplear una suela de material de rellenoconstituída por un tejido relativamente gruesa de una o de varias telas y de baja calidad. por ejemplode borras o regenerados de cáñamoalgodónyute o retamasobre la cual se monta por sus bordesel corte del calzado uniéndolo convenientemente por medio de un adhesivoy en aplicar sobre la cara exterior de la suela de relleno una pieza de tejido de cáñamo o de otro material similar de buena calidadestando esta pieza conformada como la suela pero de dimensiones menores que éstade modo que quede un márgen entre el borde de la pieza y el borde de la suelay en aplicar finalmente sobre el borde de la suela una tira de caucho crudo que cubre el borde lateral de la suela y se dobla en ángulo sobre la cara del piseocupando el márgen citado hasta cubrir el borde de la pieza central de cáñamodespués de lo cual se somete el calzado a una vulcanización en un molde apropiado.
Patent FI-20205424-A1 (FI)
Title: Method and device for recovering metal
Inventor: RINNE TERO
IPC: C25C1/00
Filed: 2020-04-28
Abstract: The present application provides a method for recovering metal from metalcontaining material by leaching, the method comprising providing aqueous solution (14) containing leaching agent precursor, providing one or more source(s) of external energy (10) comprising a source of electric current connected to one or more non-metallic electrode(s) (20), treating the aqueous solution with the external energy to form hydrogen peroxide from oxygen in the aqueous solution, reacting the leaching agent precursor with the formed hydrogen peroxide to form a leaching agent and to obtain a leaching solution, providing metal-containing material, reacting the metal-containing material with the leaching solution to obtain soluble metal complexes, and recovering the soluble metal complexes. The present application also discloses a device for recovering metal from metal-containing material by leaching.
Patent FI-20216292-A1 (FI)
Title: Method for determining whether a subject is at risk of developing a musculoskeletal and/or connective tissue disease
Inventor: WÜRTZ PETER
IPC: G01N33/92
Filed: 2021-12-17
Abstract: A method for determining whether a subject is at risk of developing a musculoskeletal and/or connective tissue disease.
Patent HK-1028599-A1 (HK)
Title: Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
Inventor: ZIMMERMANN JURG
IPC: C07D401/04
Filed: 2000-11-09
Abstract: The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula 1, which may be used for example for tumour therapy.
Patent HK-1029350-A1 (HK)
Title: Method of producing catalytic antibodies
Inventor: KOENTGEN FRANK
IPC: C07K16/18
Filed: 2000-12-29
Abstract: The present invention relates generally to a growth factor precursor and its use to select production of antigen specific catalytic antibodies. Such catalytic antibodies are produced following B cell activation and proliferation induced by catalytic cleavage products of a target antigen portion of the growth factor precursor of the present invention. A particularly useful form of the growth factor precursor is as a nucleic acid vaccine. The nucleic acid vaccine of the present invention preferably further comprises a molecular adjuvant. Another aspect of the present invention comprises a growth factor precursor in multimeric form. The growth factor precursor of the present invention is useful for generating catalytic antibodies for both therapeutic, diagnostic and industrial purposes.
Patent HK-1042455-A1 (HK)
Title: Improved tamper-evident form
Inventor: SCHEGGETMAN BERNARD WILLEM WIM
IPC: B42D15/00
Filed: 2002-06-03
Abstract: Confidential information is printed on an upper transparent laminate. A scrambling pattern is associated with a lower laminate. The upper surface of the lower laminate and the lower surface of the upper laminate are complementary in shape such that the upper laminate appears transparent, but alters to appear translucent when separated from the lower laminate. This provides a tamper-evident mechanism for indicating separation of the laminates.
Patent HK-1046245-A1 (HK)
Title: Tanacetum parthenium extract
Inventor: BOMBARDELLI EZIO
IPC: A61P/
Filed: 2002-10-30
Abstract: Extracts of Tanacetum parthenium with a reduced content of alpha-unsaturated gamma-lactones, particularly of parthenolide, obtainable by elution on basic resins are disclosed.The extracts of the invention have favourable pharmacological properties together with reduced risks of allergic reactions.
Patent HK-1057534-A1 (HK)
Title: Nitrogen containing long-term release fertilizer.
Inventor: HORCHLER KLAUS
IPC: C05C9/00
Filed: 2003-11-13
Abstract: A slow-release nitrogen-containing fertilizer (I) comprises a mixture of: <??>(a) acetylene-diurea; and <??>(b) at least one other nitrogen-containing organic fertilizer. <??>An Independent claim is included for the production of (I), by mixing powder or granules of the starting components and optionally granulating.
Patent HK-1060281-A1 (HK)
Title: Pharmaceutically active isoindoline derivatives
Inventor: MULLER GEORGE W
IPC: A61K31/454
Filed: 2004-03-09
Abstract: Isoindolin-1-one and Isoindoline-1,3-dione substituted in the 2-position with a 2,6-dioxo-3-hydroxypiperidin-5-yl group, which may be further substituted in the 5-position with alkyl or halogeno, and in the 4-position with alkyl or a nitrogen-containing group are inhibitors of, and thus useful in the treatment of disease states mediated by, TNF alpha.
Patent HK-1059531-A1 (HK)
Title: Called number translation
Inventor: VU JOE Q
IPC: H04Q3/66
Filed: 2004-04-02
Abstract: An optimal digit translation and call processing system and method is provided. A prefix translation and digit characterization process are performed utilizing a digit prefix table and a second table interfaced therewith. The digit prefix table contains numerous records corresponding to prefixes of dialed digit streams. Each record includes an index to a record of a second table operable to output a termination type of the digit stream. The second table includes numerous records associated with various call termination types. Each index included within respective records of the digit prefix table may reference more than one record of the second table. The digit stream length is analyzed to resolve ambiguities in the digit stream when an index in a record of the digit prefix table references more than one record of the second table. Multiple records of the digit prefix table may have a common index to an identical record of the second table thus reducing the required number of records in the second table for characterizing call termination types. A call screening table is interrogated with termination type data obtained from the second table. The call screening table can pass call control to a national or international translator table which provide a route index on which further call processing is performed. The route index may be modified by an originator routing table, a carrier identification code routing table and a time of day routing table before the call is ultimately routed.
Patent HK-1059603-A1 (HK)
Title: Injection molding machine
Inventor: EMOTO ATSUSHI
IPC: B29C/
Filed: 2004-04-07
Abstract: An object is to increase the mechanical efficiency of an injection molding machine, decrease the inertia, and decrease the axial length. The injection molding machine comprises a cylinder member; an injection member disposed within the cylinder member such that the injection member can advance and retract; an injection motor (82); and a transmission shaft which is connected to the injection member such that the transmission shaft can rotate relative to the injection member. The transmission shaft has a rotation transmission portion, to which rotation of the injection motor (82) is transmitted, as well as a motion conversion portion for converting rotational motion to linear motion. The injection motor (82) and the transmission shaft are disposed on the same axis, and the transmission shaft is advanced and retracted inside the rotor (92) of the injection motor (82). In this case, since rotation of the injection motor (82) is transmitted directly to the transmission shaft without intervention of a speed reduction mechanism, a pulley, and the like, mechanical efficiency can be improved, and inertia can be decreased. Further, the time required for changeover from the injection stage to the pressure holding stage is shortened. Since the transmission shaft is advanced and retracted inside the rotor (92) of the injection motor (82), the injection molding machine can be reduced in axial length. <IMAGE>
Patent HK-1060363-A1 (HK)
Title: Method for producing benzoxazine resin
Inventor: AIZAWA TERUKI
IPC: C08G14/073
Filed: 2004-05-11
Abstract: The present invention discloses a process for producing a benzoxazine resin which comprises the steps of reacting a phenol compound, an aldehyde compound and a primary amine in the presence of an organic solvent to synthesize a benzoxazine resin and removing generated condensation water and the organic solvent from a system under heating and a reduced pressure, wherein a pressure in the reaction system at the time of removal is set to 260 mmHg or higher.
Patent HK-1063847-A1 (HK)
Title: Method for spectrometrically measuring isotopic gas
Inventor: KUBO YASUHIRO
IPC: G01N21/35
Filed: 2004-09-07
Abstract: The present invention relates to a method for spectrometrically measuring an isotopic gas comprising the steps of introducing a gaseous test sample containing a plurality of component gases including  12 CO 2  and  13 CO 2  into a cell, measuring intensity of light transmitted through the gaseous test sample at wavelengths suitable for the respective component gases, and processing data of the light intensity to determine concentrations of the component gases in the gaseous test sample, the method comprising a first step of introducing the gaseous test sample into the cell and measuring absorbances of the respective component gases in the gaseous test sample; a second step of determining concentrations and concentration ratios of the component gases in the gaseous test sample on the basis of calibration curves; and a third step of obtaining concentration ratio correction values for the component gases on the basis of the concentrations of the component gases obtained in the second step by using correction curves preliminary prepared by measuring absorbances of the component gases in gaseous samples containing the respective component gases in known concentrations with known concentration ratios, determining concentrations and concentration ratios of the component gases in the gaseous samples on the basis of the calibration curves, and by plotting the thus determined concentrations and concentration ratios of the component gases in the gaseous samples, and respectively dividing the concentration ratios of the component gases obtained in the second step by the concentration ratio correction values for the component gases, thereby correcting the concentration ratios of the component gases in the gaseous test sample.
Patent HK-1071286-A1 (HK)
Title: Baloon catheter with non-deployable stent
Inventor: FARNAN ROBERT C
IPC: A61M/
Filed: 2005-05-13
Abstract: An angioplasty balloon including a non-deployable stent to prevent or reduce the potential for slippage of the inflated balloon with respect to the vessel wall being treated. The balloon includes a non-deployable stent that is adapted to be secured to the balloon or angioplasty balloon catheter. The stent has a proximal end, a distal end, and at least three radially-spaced struts, each, each strut connecting the proximal end to the distal end and having one or more bends that allow expansion of the strut to accommodate the inflation of the balloon. The stent is made or a material so that the stent collapses upon deflation of the balloon.
Patent HK-1074375-A1 (HK)
Title: Characterization of moving objects in a stationary background
Inventor: GRINVALD AMIRAM
IPC: A61B/
Filed: 2005-07-12
Abstract: A method and system for determination and mapping the quantity of chromophores having a distinct spectrum attached to moving objects in an spectrally rich environment that may include multiple chromophores attached to stationary objects. Au area of interest is imaged at different times and different wavelengths, and the spectral properties of the chromophores attached to the moving objects are separated from the stationary spectral properties of the background, followed by spectral analysis of the moving objects to determine their quantity. Application to the retinal vasculature is illustrated, showing the imaging, analyzing and quantifying of the oxygen saturation of retinal blood, resolved for the different vascular compartments, including capillaries, arterioles, venules, arteries, and veins.
Patent HK-1080091-A1 (HK)
Title: Immunoassays for specific determination of scca isoforms
Inventor: EVA RÖJER
IPC: C07K/
Filed: 2006-01-04
Abstract: The present invention relates to monoclonal antibodies capable of distinguishing squamous cell cancer antigens, SCCA, in either free or complex bound forms, preferably antigens SCCA1 and SCCA2, as well as hybridomas recognizing such antibodies, method for diagnosing SCC, as well as diagnostic kits for detecting SCCAs.
Patent HK-1080856-A1 (HK)
Title: Compounds having selective inhibiting effect at gsk3
Inventor: BERG STEFAN
IPC: A61P25/00
Filed: 2006-01-19
Abstract: The present invention relates to new compounds of formula I   
wherein: Z is N and X is CH or N; Y is CONR 5 ; P is phenyl or a 5 or 6 membered heteroaromatic ring containing one or more heteroatoms selected from N, O or S; Q is phenyl or a 5 or 6 membered aromatic heterocyclicc ring containing one or more nitrogen atoms; 
R is C 1-6 alkylNR 10 R 11  or C 1-6 alkylazetidine; R 10  is hydrogen, C 1 - 6 alkyl, C 2-6 alkenyl, C 2 - 6 alkynyl, C 0 - 6 alkylC 3 - 6 cycloalkyl, C 0 - 6 alkylaryl, C 0 - 6 alkylheteroaryl or C 1 - 6 alkylNR 8 R 9 ; R 11  is C 1 - 6 alkylNR 8 R 9 , C 1 - 6 alkylC 3 - 6 cycloalkyl or C 0 - 6 alkylheterocycloalkyl; as a free base or a pharmaceutically acceptable salt, solvate or solvate of salt thereof, a process for their preparation and new intermediates used therein, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy.
Patent HK-1094582-A1 (HK)
Title: Process for producing pentacyclic taxane
Inventor: IMURA AKIHIRO
IPC: C07D/
Filed: 2007-02-15
Abstract: Taxan derivatives are produced efficiently and inexpensively, which are useful as oral-administrable antitumor compounds.  A compound of formula (1) (wherein R 1  is an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, an aryl group or a heterocyclic group; R 2  is a hydroxyl group optionally having a protective group) is processed with an alkali metal permanganate to produce a compound of formula (2), which may be a starting material for oral-administrable antitumor compounds.
Patent HK-1096527-A1 (HK)
Title: Headphone with behind-the-head headband
Inventor: MILDE LARS
IPC: H04R5/033
Filed: 2007-03-30
Abstract: There is provided a headphone with a behind-the-head headband comprising at least one transducer and a behind-the-head headband for receiving the transducer. The behind-the-head headband further comprises first and second contact locations for resting against a temporal bone of a wearer of the headphone. The spacing between the transducer and the first or second contact location can be adjusted. By virtue of the possibility of adjusting the spacing with respect to the contact location the transducer can be positioned exactly over the auditory channel of the headphone wearer without pressure points on the ear.
Patent HK-1099782-A1 (HK)
Title: Elastomer composite blends and methods for producing them
Inventor: MABRY MELINDA ANN
IPC: C08L21/00
Filed: 2007-05-29
Abstract: Elastomer composite blends are produced by novel wet/dry mixing methods and apparatus. In the wet mixing step or stage, fluid streams of particulate filler and elastomer latex are fed to the mixing zone of a coagulum reactor to form a mixture in semi-confined flow continuously from the mixing zone through a coagulum zone to a discharge end of the reactor. The particulate filler fluid is fed under high pressure to the mixing zone, such as to form a jet stream to entrain elastomer latex fluid sufficiently energetically to substantially completely coagulate the elastomer with the particulate filler prior to the discharge end. Highly efficient and effective elastomer coagulation is achieved without the need for a coagulation step involving exposure to acid or salt solution or the like. Elastomer composites are produced. Such elastomer composites may be cured or uncured, and combine material properties, such as choice of filler, elastomer, level of filler loading, and macro-dispersion, nor previously achieved. The coagulum produced by such wet mixing step, with or without intermediate processing steps, is then mixed with additional elastomer in a dry mixing step or stage to form elastomer composite blends. The additional elastomer to the coagulum may be the same as or different from the elastomer(s) used in the wet mixing step. <IMAGE>